Advancements in radiotherapy for lung cancer in China

查看全文 作　　者：Lujun [1]Zhao;Luhua [2]Wang

机构地区：[1]Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy;[2]Department of Radiation Oncology, Cancer Hospital and Institute, Chinese Academy of Medical Science and Peking Union Medical College

出　　处：《The Chinese-German Journal of Clinical Oncology》索引2015年第14卷第1期,共10页

摘　　要：Lung cancer is the leading cause of death due to cancer in China. In recent years, great progress has been made in radiotherapy for lung cancer patients in China. The main advancements include the following aspects:(1) stereotactic ablative radiotherapy for early stage nonsmall cell lung cancer(NSCLC),(2) post-operative radiotherapy for NSCLC,(3) combined chemotherapy and radiotherapy for locally advanced NSCLC,(4) improved radiotherapy for advanced NSCLC, and 5) prediction of radiation-induced lung toxicity. 关键词：非小细胞肺癌放射治疗中国立体定向辐射诱发放疗死亡化疗

相关文献

参考文献（101）
引证文献（0）
耦合文献（318）

参考文献(101)

耦合文献(318)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

Advancements in radiotherapy for lung cancer in China

参考文献(101)

耦合文献(318)

用户提示